Locations:
Search IconSearch
April 4, 2018/Cancer/News & Insight

Social Media and Journal Clubs: The Ultimate Peer Review?

An oncologist weighs in

social-media_650x450

ByAaron Gerds, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The Cotton Club, The Breakfast Club and journal club. Like other legendary clubs, journal club has centered around an in-person gathering to facilitate the exchange of commentary and ideas on a given topic. The critical evaluation of recent articles conducted in journal clubs serves as a building block for medical education, evidence-based guidelines and quality improvement initiatives. From residency training, I have very vivid — dare I say fond? — memories of journal club at Hines VA Hospital getting into the nitty gritty of numbers needed to treat with then Chairman Brian Schmitt, MD, MPH. For the past 180 years, from Sir James Paget to Gordon Guyatt, MD, MSc, journal clubs have been steadfast with a very gradual evolution, but the technology revolution is shaking things up.

Social media, including Twitter, has changed the way we communicate. In addition to focused composition and the introduction of emoji, it has also eliminated distance and time. Discussions including thousands can be had instantly across the globe. It has been argued that social media has dumbed down discourse, reducing it to a series of likes or retweets. Despite its limitations, it can be a powerful tool in the appraisal of the medical literature.

With most manuscripts posted on publishers’ websites well in advance of print, the peer review process can occur almost instantaneously. Social media also enables the readership to interact directly with the authors.

With such a large volume of users, critiques presented and validated are essentially crowdsourced, and conversely, individuals can provide insight on how local context may affect the application of results in their own practice. Social media invites its users to come off the bench and get into the game, identifying quality and refuting misinterpretation by a simple post for many, with others taking the next step into content creation. One key element yet to be clarified as things move forward is how these contributions will be measured and how faculty will get academic credit for participating in online forums.

Advertisement

While time will tell if Twitter and social media are the ultimate peer review, it is clear that they can be a powerful tool in conducting academic medicine. I wonder if William Osler would share his critiques in 280 characters or less.

Dr. Gerds is a staff physician in the Department of Hematology and Medical Oncology and publishes in medical literature about social media use. Follow him on Twitter @AaronGerds.

Advertisement

Related Articles

Patient with nurse

Supporting our Patients Living with Cancer and Beyond

Reframing cancer survivorship

Dr. Jack Khouri with patient

A Call to Increase Awareness About AL Amyloidosis

New guidelines empower clinicians with practical diagnostic framework

Dr. Shilpa Gupta and patient
April 30, 2026/Cancer/Tumor Oncology

Bladder Cancer Treatment Takes Key Steps Forward

Pivotal Studies Guide Treatment Decisions in Muscle-Invasive Bladder Cancer

Dr. Timothy Gilligan
April 27, 2026/Cancer/Patient Support

Getting Tough Conversations Right in Cancer Care

Reflections from an oncology provider and communications educator on new ASCO Guidelines on Patient-Clinician Communication

p53 mutation illustration
April 22, 2026/Cancer/News & Insight

Study Holds Promise for Targeting Elusive P53 Gene Mutation

Phase 1 trial outcomes offer encouraging news for developing targeted therapy for solid tumors

Synovial sarcoma cells
April 20, 2026/Cancer/News & Insight

T-Cell Receptor Therapy Available for Segment of Population with Synovia Sarcoma

Cleveland Clinic to administer first-of-its-kind T-cell therapy

Dr. Jagadeesh and patient
April 14, 2026/Cancer/News & Insight

Bispecific Antibody Shows Deep Remission in Patients with Relapsed/Refractory Follicular Lymphoma

Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy

Endoscopic nipple-sparing mastectomy

Case Study: Endoscopic Nipple-Sparing Bilateral Mastectomy Improves Outcomes

Innovative procedure reduces scarring, recovery time and nipple sensation

Ad